{"description":"The safety population included all participants who received at least one dose of study medication.","eventGroups":[{"deathsNumAffected":18,"deathsNumAtRisk":154,"description":"Participants with completely resected Stage IIC, IIIA, or IIIB cutaneous melanoma) received vemurafenib, 960 mg twice daily, in 28-day cycles, for up to 52 weeks","id":"EG000","otherNumAffected":150,"otherNumAtRisk":154,"seriousNumAffected":25,"seriousNumAtRisk":154,"title":"Cohort 1 Vemurafenib"},{"deathsNumAffected":33,"deathsNumAtRisk":156,"description":"Participants with completely resected Stage IIC, IIIA, or IIIB cutaneous melanoma) received vemurafenib-matching placebo twice daily, in 28-day cycles, for up to 52 weeks","id":"EG001","otherNumAffected":117,"otherNumAtRisk":156,"seriousNumAffected":16,"seriousNumAtRisk":156,"title":"Cohort 1 Placebo"},{"deathsNumAffected":25,"deathsNumAtRisk":93,"description":"Participants with Stage IIIC cutaneous melanoma received vemurafenib, 960 mg twice daily, in 28-day cycles, for up to 52 weeks","id":"EG002","otherNumAffected":92,"otherNumAtRisk":93,"seriousNumAffected":15,"seriousNumAtRisk":93,"title":"Cohort 2 Vemurafenib"},{"deathsNumAffected":26,"deathsNumAtRisk":91,"description":"Participants with Stage IIIC cutaneous melanoma received vemurafenib-matching placebo twice daily, in 28-day cycles, for up to 52 weeks","id":"EG003","otherNumAffected":67,"otherNumAtRisk":91,"seriousNumAffected":9,"seriousNumAtRisk":91,"title":"Cohort 2 Placebo"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":57,"numAtRisk":154},{"groupId":"EG001","numAffected":20,"numAtRisk":156},{"groupId":"EG002","numAffected":34,"numAtRisk":93},{"groupId":"EG003","numAffected":10,"numAtRisk":91}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":57,"numAtRisk":154},{"groupId":"EG001","numAffected":10,"numAtRisk":156},{"groupId":"EG002","numAffected":37,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Alopecia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":44,"numAtRisk":154},{"groupId":"EG001","numAffected":27,"numAtRisk":156},{"groupId":"EG002","numAffected":28,"numAtRisk":93},{"groupId":"EG003","numAffected":3,"numAtRisk":91}],"term":"Pruritus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":52,"numAtRisk":154},{"groupId":"EG001","numAffected":6,"numAtRisk":156},{"groupId":"EG002","numAffected":35,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hyperkeratosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":58,"numAtRisk":154},{"groupId":"EG001","numAffected":5,"numAtRisk":156},{"groupId":"EG002","numAffected":25,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Photosensitivity reaction"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":32,"numAtRisk":154},{"groupId":"EG001","numAffected":13,"numAtRisk":156},{"groupId":"EG002","numAffected":16,"numAtRisk":93},{"groupId":"EG003","numAffected":5,"numAtRisk":91}],"term":"Dry skin"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":154},{"groupId":"EG001","numAffected":8,"numAtRisk":156},{"groupId":"EG002","numAffected":17,"numAtRisk":93},{"groupId":"EG003","numAffected":6,"numAtRisk":91}],"term":"Erythema"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":154},{"groupId":"EG001","numAffected":8,"numAtRisk":156},{"groupId":"EG002","numAffected":4,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Actinic keratosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":101,"numAtRisk":154},{"groupId":"EG001","numAffected":37,"numAtRisk":156},{"groupId":"EG002","numAffected":49,"numAtRisk":93},{"groupId":"EG003","numAffected":17,"numAtRisk":91}],"term":"Arthralgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":31,"numAtRisk":154},{"groupId":"EG001","numAffected":15,"numAtRisk":156},{"groupId":"EG002","numAffected":17,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Pain in extremity"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":154},{"groupId":"EG001","numAffected":10,"numAtRisk":156},{"groupId":"EG002","numAffected":9,"numAtRisk":93},{"groupId":"EG003","numAffected":3,"numAtRisk":91}],"term":"Myalgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":154},{"groupId":"EG001","numAffected":8,"numAtRisk":156},{"groupId":"EG002","numAffected":7,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Musculoskeletal pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":154},{"groupId":"EG001","numAffected":14,"numAtRisk":156},{"groupId":"EG002","numAffected":7,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Back pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":52,"numAtRisk":154},{"groupId":"EG001","numAffected":52,"numAtRisk":156},{"groupId":"EG002","numAffected":26,"numAtRisk":93},{"groupId":"EG003","numAffected":18,"numAtRisk":91}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":154},{"groupId":"EG001","numAffected":13,"numAtRisk":156},{"groupId":"EG002","numAffected":17,"numAtRisk":93},{"groupId":"EG003","numAffected":10,"numAtRisk":91}],"term":"Asthenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":28,"numAtRisk":154},{"groupId":"EG001","numAffected":11,"numAtRisk":156},{"groupId":"EG002","numAffected":16,"numAtRisk":93},{"groupId":"EG003","numAffected":7,"numAtRisk":91}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":154},{"groupId":"EG001","numAffected":8,"numAtRisk":156},{"groupId":"EG002","numAffected":7,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Oedema peripheral"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":59,"numAtRisk":154},{"groupId":"EG001","numAffected":36,"numAtRisk":156},{"groupId":"EG002","numAffected":27,"numAtRisk":93},{"groupId":"EG003","numAffected":9,"numAtRisk":91}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":38,"numAtRisk":154},{"groupId":"EG001","numAffected":32,"numAtRisk":156},{"groupId":"EG002","numAffected":27,"numAtRisk":93},{"groupId":"EG003","numAffected":9,"numAtRisk":91}],"term":"Diarrhoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":154},{"groupId":"EG001","numAffected":9,"numAtRisk":156},{"groupId":"EG002","numAffected":14,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Vomiting"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":154},{"groupId":"EG001","numAffected":11,"numAtRisk":156},{"groupId":"EG002","numAffected":9,"numAtRisk":93},{"groupId":"EG003","numAffected":3,"numAtRisk":91}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":154},{"groupId":"EG001","numAffected":7,"numAtRisk":156},{"groupId":"EG002","numAffected":6,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Abdominal pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":29,"numAtRisk":154},{"groupId":"EG001","numAffected":32,"numAtRisk":156},{"groupId":"EG002","numAffected":20,"numAtRisk":93},{"groupId":"EG003","numAffected":11,"numAtRisk":91}],"term":"Headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":154},{"groupId":"EG001","numAffected":4,"numAtRisk":156},{"groupId":"EG002","numAffected":8,"numAtRisk":93},{"groupId":"EG003","numAffected":3,"numAtRisk":91}],"term":"Dysgeusia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":154},{"groupId":"EG001","numAffected":2,"numAtRisk":156},{"groupId":"EG002","numAffected":19,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Skin papilloma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":154},{"groupId":"EG001","numAffected":7,"numAtRisk":156},{"groupId":"EG002","numAffected":10,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Seborrhoeic keratosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":10,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Keratoacanthoma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":28,"numAtRisk":154},{"groupId":"EG001","numAffected":5,"numAtRisk":156},{"groupId":"EG002","numAffected":14,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Alanine aminotransferase increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":154},{"groupId":"EG001","numAffected":5,"numAtRisk":156},{"groupId":"EG002","numAffected":11,"numAtRisk":93},{"groupId":"EG003","numAffected":3,"numAtRisk":91}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":154},{"groupId":"EG001","numAffected":2,"numAtRisk":156},{"groupId":"EG002","numAffected":19,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Sunburn"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":154},{"groupId":"EG001","numAffected":11,"numAtRisk":156},{"groupId":"EG002","numAffected":16,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Decreased appetite"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":154},{"groupId":"EG001","numAffected":7,"numAtRisk":156},{"groupId":"EG002","numAffected":12,"numAtRisk":93},{"groupId":"EG003","numAffected":4,"numAtRisk":91}],"term":"Insomnia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":154},{"groupId":"EG001","numAffected":8,"numAtRisk":156},{"groupId":"EG002","numAffected":6,"numAtRisk":93},{"groupId":"EG003","numAffected":3,"numAtRisk":91}],"term":"Cough"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":154},{"groupId":"EG001","numAffected":10,"numAtRisk":156},{"groupId":"EG002","numAffected":4,"numAtRisk":93},{"groupId":"EG003","numAffected":7,"numAtRisk":91}],"term":"Nasopharyngitis"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Pericarditis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Vertigo positional"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Leukoplakia oral"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Pancreatitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Pancreatitis acute"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Chest pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Bile duct stone"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Appendicitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Bronchitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":2,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Cellulitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Groin infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hepatitis B"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Soft tissue infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Electrocardiogram QT prolonged"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Lipase increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hyperlipasaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hypokalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hypophosphataemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Arthralgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Dupuytren's contracture"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Acute promyelocytic leukaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Atypical fibroxanthoma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":154},{"groupId":"EG001","numAffected":7,"numAtRisk":156},{"groupId":"EG002","numAffected":3,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Basal cell carcinoma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Malignant melanoma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":2,"numAtRisk":91}],"term":"Prostate cancer"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Squamous cell carcinoma of skin"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Thyroid cancer"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Carotid artery stenosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Facial paralysis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Pleuritic pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Actinic keratosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Dermatitis exfoliative"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Drug reaction with eosinophilia and systemic symptoms"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Rash papular"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hypotension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Pelvic venous thrombosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":2,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Atrial fibrillation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Coronary artery occlusion"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Myocardial infarction"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Iridocyclitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Inguinal hernia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hepatic function abnormal"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Erysipelas"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Infected skin ulcer"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Gastrointestinal stromal tumour"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Neuroendocrine carcinoma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Suicidal ideation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Pneumothorax"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":1,"numAtRisk":156},{"groupId":"EG002","numAffected":1,"numAtRisk":93},{"groupId":"EG003","numAffected":0,"numAtRisk":91}],"term":"Hypertension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Lymphadenopathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA, Version 19.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":154},{"groupId":"EG001","numAffected":0,"numAtRisk":156},{"groupId":"EG002","numAffected":0,"numAtRisk":93},{"groupId":"EG003","numAffected":1,"numAtRisk":91}],"term":"Pancreatic neuroendocrine tumour"}],"timeFrame":"Up to the data cutoff of July 13, 2018 (approximately 6 years)."}